Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2014-03-18

Original market date: See footnote 1

1979-12-31

Product name:

PATENT BLUE SODIUM INJECTION

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

00405396

Product Monograph/Veterinary Labelling:

Date: 2017-03-07 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

GUERBET
Bp 57400
Roissy Cdg Cedex
Val-D'Oise
France 95943

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

36:89.00* See footnote6 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V04CX OTHER DIAGNOSTIC AGENTS

Active ingredient group (AIG) number:See footnote5

0112398001

List of active ingredient(s)
Active ingredient(s) Strength
PATENT BLUE SODIUM 50 MG / 2 ML
Version 4.0.2
Date modified: